Cheng-Han Chen, MD, PhD, is the medical director of the structural coronary heart program at MemorialCare Saddleback Medical Heart in Laguna Hills, California, and director of structural and interventional cardiology at Pacific Cardiovascular Associates Medical Group.
Dr. Chen accomplished his bachelor’s and grasp’s levels at MIT in supplies science and engineering. He obtained his MD diploma from UCSD and his PhD in bioengineering from UCLA.
As a medical gadget engineer at Medtronic, Chen performed an necessary function within the improvement of the Endeavor and Resolute drug-eluting coronary stents. His internship and residency had been accomplished at UCLA, the place he additionally accomplished his heart problems fellowship. He went on to finish each interventional cardiology fellowship adopted by structural coronary heart illness fellowship at NewYork-Presbyterian/Columbia College Hospital. Whereas at Columbia, he was intently concerned within the main scientific trials involving transcatheter aortic valve alternative (TAVR).
Chen has introduced his analysis at main nationwide and worldwide conferences together with the American Coronary heart Affiliation (AHA), American Faculty of Cardiology (ACC), and Transcatheter Cardiovascular Therapeutics (TCT), and has authored a number of manuscripts and e book chapters on topics starting from interventional cardiology to cardiac stem cells. Previous to his present roles, he served on school of Columbia College Medical Heart as a scientific teacher.
Outdoors of the workplace, Chen enjoys spending time along with his spouse and youngsters. He’s additionally an completed violinist.
